Praxsyn Corp (PXYN)

[cdhames]

None of that really matters.

The only risk is that NHS doesn't perform to expectation, in which case PXYN will be forced to pursue another marketing/billings service.

What you're arguing is sales channels. PXYN needs to further expand their revenue channels. 4-6 of these agreements with different, non-exclusive companies would fortify their revenue position. They are still at risk, but because of the lack of diversification of revenue streams.

Not because of the type of contract they signed.